Cota-Watson Effort Aims at Optimal Cost Margins as Well as Improved Care

Brandon May
Published: Friday, Aug 25, 2017
Stuart L. Goldberg, MD

Stuart L. Goldberg, MD
Investigators at Cota, a New York medical data analytics company, are taking further strides toward putting their growing knowledge of variance in care to work in the clinical setting. This involves both an understanding of which types of treatment get optimal results and knowing which forms of therapy are liable to meet with least resistance from payers, said Stuart L. Goldberg, MD, chief medical officer.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Publication Bottom Border
Border Publication